These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31757080)

  • 41. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Orthosteric and/or Allosteric Binding of α-Conotoxins to Nicotinic Acetylcholine Receptors and Their Models.
    Kryukova EV; Ivanov IA; Lebedev DS; Spirova EN; Egorova NS; Zouridakis M; Kasheverov IE; Tzartos SJ; Tsetlin VI
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30469507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins.
    Kudryavtsev D; Shelukhina I; Vulfius C; Makarieva T; Stonik V; Zhmak M; Ivanov I; Kasheverov I; Utkin Y; Tsetlin V
    Toxins (Basel); 2015 May; 7(5):1683-701. PubMed ID: 26008231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depressant and convulsant barbiturates both inhibit neuronal nicotinic acetylcholine receptors.
    Watanabe I; Andoh T; Furuya R; Sasaki T; Kamiya Y; Itoh H
    Anesth Analg; 1999 Jun; 88(6):1406-11. PubMed ID: 10357353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.
    Marubio LM; Gardier AM; Durier S; David D; Klink R; Arroyo-Jimenez MM; McIntosh JM; Rossi F; Champtiaux N; Zoli M; Changeux JP
    Eur J Neurosci; 2003 Apr; 17(7):1329-37. PubMed ID: 12713636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
    Mohammadi SA; Christie MJ
    Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors.
    Giribaldi J; Dutertre S
    Neurosci Lett; 2018 Jul; 679():24-34. PubMed ID: 29199094
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus.
    Alkondon M; Pereira EF; Almeida LE; Randall WR; Albuquerque EX
    Neuropharmacology; 2000 Oct; 39(13):2726-39. PubMed ID: 11044743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicotinic receptor partial agonists alter catecholamine homeostasis and response to nicotine in PC12 cells.
    Turcanu DS; Kirtok N; Eibl C; Guendisch D; LaGamma EF; Nankova BB
    Neurosci Lett; 2012 May; 516(2):212-6. PubMed ID: 22503726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nicotine facilitates nicotinic acetylcholine receptor targeting to mitochondria but makes them less susceptible to selective ligands.
    Uspenska K; Lykhmus O; Gergalova G; Chernyshov V; Arias HR; Komisarenko S; Skok M
    Neurosci Lett; 2017 Aug; 656():43-50. PubMed ID: 28700952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
    Nai Q; McIntosh JM; Margiotta JF
    Mol Pharmacol; 2003 Feb; 63(2):311-24. PubMed ID: 12527802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
    Azam L; McIntosh JM
    Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of nicotinic acetylcholine receptor-mediated [(3)H]-dopamine release from rat cortex and striatum.
    Puttfarcken PS; Jacobs I; Faltynek CR
    Neuropharmacology; 2000 Oct; 39(13):2673-80. PubMed ID: 11044737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
    Barik J; Wonnacott S
    Mol Pharmacol; 2006 Feb; 69(2):618-28. PubMed ID: 16269536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain.
    Whiteaker P; McIntosh JM; Luo S; Collins AC; Marks MJ
    Mol Pharmacol; 2000 May; 57(5):913-25. PubMed ID: 10779374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indolizidine (-)-235B' and related structural analogs: discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release.
    Pivavarchyk M; Smith AM; Zhang Z; Zhou D; Wang X; Toyooka N; Tsuneki H; Sasaoka T; McIntosh JM; Crooks PA; Dwoskin LP
    Eur J Pharmacol; 2011 May; 658(2-3):132-9. PubMed ID: 21371454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens.
    Jerlhag E; Egecioglu E; Dickson SL; Svensson L; Engel JA
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):508-18. PubMed ID: 18343642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M; Hellström-Lindahl E
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
    Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
    Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.